|
|
||||||||
1 Children's Hospital, Technical University of Munich, 80804 Munich, Germany; and 2 John B. Pierce Laboratory and Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06519
| |
ABSTRACT |
|---|
|
|
|---|
The impact of body core
heating on the interaction between the cutaneous and central
circulation during blood pressure challenges was examined in eight
adults. Subjects were exposed to
10 to
90 mmHg lower body
negative pressure (LBNP) in thermoneutral conditions and
10 to
60 mmHg LBNP during heat stress. We measured forearm vascular
conductance (FVC;
ml · min
1 · 100 ml
1 · mmHg
1) by
plethysmography; cutaneous vascular conductance (CVC) by laser-Doppler
techniques; and central venous pressure, arterial blood pressure, and
cardiac output by impedance cardiography. Heat stress increased FVC
from 5.7 ± 0.9 to 18.8 ± 1.3 conductance units (CU) and CVC from
0.21 ± 0.07 to 1.02 ± 0.20 CU. The FVC-CVP relationship was linear
over the entire range of LBNP and was shifted upward during heat stress
with a slope increase from 0.46 ± 0.10 to 1.57 ± 0.3 CU/mmHg CVP
(P < 0.05). Resting CVP was lower during heat stress (6.3 ± 0.6 vs. 7.7 ± 0.6 mmHg; P < 0.05) but fell to
similar levels during LBNP as in normothermic conditions. Data analysis
indicates an increased capacity, but not sensitivity, of peripheral
baroreflex responses during heat stress. Laser-Doppler techniques
detected thermoregulatory responses in the skin, but no significant
change in CVC occurred during mild-to-moderate LBNP. Interestingly,
very high levels of LBNP produced cutaneous vasodilation in some subjects.
forearm blood flow; baroreceptor; central venous pressure; lower body negative pressure
| |
INTRODUCTION |
|---|
|
|
|---|
IN HUMANS, THERMAL STATUS is believed to impact the response of the peripheral circulation to cardiovascular reflexes. For example, during heat stress the relative reduction in forearm vascular conductance (FVC) during orthostatic stress is more pronounced, but the absolute values remain above those levels reached in a normothermic state (2, 7, 13). The interpretation of these data has been consistent. The change in FVC is too large to be solely attributed to vasomotor adjustments in skeletal muscle. Thus a response in the cutaneous circulation has been implicated. However, the dose-response relationship between peripheral and central hemodynamic variables in different thermal conditions has not been defined.
Laser-Doppler velocimetry has been used to specifically examine
cutaneous blood flow responses to thermoregulatory and
baroreflexes. Studies adopting this method have provided
controversial results. Kellogg and co-workers (11) used local
iontophoresis of bretylium tosylate for selective presynaptic blockade
of the cutaneous
-adrenergic vasoconstrictor system. In normothermic
conditions, cutaneous vascular conductance (CVC) was reduced during
40 mmHg lower body negative pressure (LBNP) in the untreated,
but not in the treated, skin site. During whole body heating (skin
temperature >38°C), LBNP induced equal CVC reductions in both
skin sites, suggesting withdrawal of vasodilator tone. Interestingly,
after the subjects were returned to normothermia the untreated skin
site no longer responded to LBNP. In a similar protocol, Crandall and
co-workers (1) examined the relative contribution of the
cardiopulmonary and the carotid baroreceptors in the regulation of
cutaneous blood flow. Application of
30 mmHg LBNP in
normothermic conditions reduced FVC and CVC. When skin temperature was
increased to 38°C, application of
5 or
10 mmHg LBNP
did not affect CVC but reduced FVC, suggesting that only muscle, but
not skin, blood flow had changed. During
30 mmHg LBNP, CVC and
FVC were reduced. The protocol was repeated by using pulsatile carotid
pressure to selectively unload carotid baroreceptors. This stimulus
increased heart rate (HR) and blood pressure, but neither CVC nor FVC
responded. These data support the primary role of cardiopulmonary
baroreceptors in mediating the change in CVC and FVC during LBNP. In
contrast, studies by Ryan et al. (20) suggest a predominant role of
arterial baroreceptors in the control of ear blood flow in rabbits.
Intact animals and animals with sinoaortic denervation were exposed to whole body heating to maximize vascular conductance in the ear. Neither
pharmacological blockade nor mechanical unloading of the low-pressure
baroreceptors induced a vasoconstrictor response. However, ramp
decreases of arterial blood pressure triggered reductions in ear blood
flow in the animals with intact arterial baroreceptors.
In humans, Vissing and co-workers (25) combined laser-Doppler
velocimetry with measurements of sympathetic nerve activity to skin and
muscle. In normothermia, application of
5,
10, and
15 mmHg LBNP increased muscle sympathetic nerve
activity without a change in skin sympathetic nerve activity. In heated
subjects, application of
15 mmHg LBNP reduced CVC, but these
changes were also produced by sham LBNP that created an air current
over the lower body but no negative pressure in the LBNP box. The CVC
response during sham LBNP was abolished by local skin heating that
prevented a drop in skin temperature. In another study, the same group
(26) was unable to measure any changes in skin blood flow or
sympathetic nerve activity in 13 subjects exposed to 20 min of
50 mmHg LBNP. These observations do not support the concept that
the skin participates importantly in baroreceptor-mediated reflexes. In
fact, they argue that thermoregulatory reflexes responding to changes
in skin temperature mediate the change in skin blood flow during LBNP,
when observed. Data from our laboratory (14) show a marked
heterogeneity in the skin blood flow response to LBNP within a given
1-cm2 area of skin. At present, it is unclear
which factors contribute to the observed discrepancy in the CVC
response to LBNP.
One potential problem with studies examining the integration of
thermoregulatory and baroreflexes is that heat stress is commonly evoked by direct skin heating to nonphysiological temperatures
38°C. Under such circumstances, local vascular responses to high temperatures (over the majority of the skin surface) may modify vasoregulatory signals from the central nervous system or the response
of effector organs to these signals (17, 21). More importantly, the
dominant afferent sensory input into the thermoregulatory control
system is body core and not skin temperature. The present study
examined the impact of body core temperature on the baroreflex control
of skin blood flow at physiological skin temperatures. We were
particularly interested the interaction between the cutaneous and the
central circulation and used graded LBNP to very high levels to analyze
the dose-response relationship of the evoked changes. Standard
plethysmographic measurements of forearm blood flow were combined with
laser-Doppler measurements of skin blood flow in an untreated and a
bretylium-treated skin site as described by Kellogg et al. (10).
| |
METHODS |
|---|
|
|
|---|
Subjects
Eight healthy subjects (nonsmokers: 3 women, 5 men) gave written, informed consent to participate in the study. Their mean (range) physical characteristics were age 32 (24-38) yr, weight 70.3 (55.6-86.4) kg, and height 173.6 (156-191) cm. On a separate day, before the experiment, all subjects were thoroughly familiarized with the experimental procedure. On the day of the experiment, they had a light breakfast but no caffeine-containing drinks. All experiments were conducted in the late morning. The Yale University School of Medicine Human Investigation Committee approved the protocol.Experimental Protocol
Two hours before the subjects entered the environmental test chamber, two skin sites on the volar side of the left forearm were chosen for measurement of skin blood flow with laser-Doppler velocimetry. Bretylium tosylate was applied locally to the skin by iontophoresis to block transmittor release from sympathetic vasoconstrictor nerve terminals, as described by Kellogg et al. (10). A LectroPatch (General Medical, Los Angeles, CA) iontophoresis unit, consisting of two adjacent yet separate treatment compartments, was used. In each compartment, a 3.1-cm2 treatment pad was placed and soaked with 1.5 ml of either bretylium tosylate (100 mM) or vehicle (pure water). The iontophoresis protocol consisted of 20 min at a current density of 160 µA/cm2 followed by 20 min at a current density of 80 µA/cm2.Experimental preparation of the subjects occurred within the environmental chamber at an ambient temperature of 28°C. Subjects wore a tubed-lined garment perfused with water at 34°C and lay supine within the LBNP box. Their lower legs were immersed in 34°C water for ~30-45 min during catheter placement and instrumentation. After experimental preparation, subjects were allowed to rest undisturbed for 15 min before baseline measurements were performed. Next, cold stress was applied for a period of ~4 min by perfusion of cold (5°C) water through the garment to demonstrate thermoregulatory-mediated reflex cutaneous vasoconstriction at the untreated skin site and effective local vasoconstrictor blockade in the bretylium-treated skin site by using laser-Doppler velocimetry.
After cold stress, the water circulating though the liquid perfusion
garment was returned to 34°C, and another 15-min rest period served
to return the subjects to thermoneutral conditions. Data were then
collected during 2 min of control, 2 min of each level of LBNP, and 2 min of recovery. In the thermoneutral state, LBNP was applied in a
graded stepwise fashion by using
10,
20,
30, and
40 mmHg. The higher levels of LBNP,
60,
75, and
90 mmHg, were applied individually. To avoid arousal responses,
LBNP was increased slowly over ~30 s before reaching the final level. After the last LBNP level, subjects were then passively heated by
raising the lower leg water bath temperature to 44°C. Within 25-30 min, body core temperature (esophageal temperature) had reached a new plateau, and LBNP was repeated in a graded stepwise fashion by using
10,
20, and
30 mmHg LBNP. Higher
levels of LBNP (
40 and
60 mmHg) were applied as separate
perturbations. To avoid syncope, heated subjects were not exposed to
LBNP greater than
60 mmHg. After each experimental episode,
baseline conditions were regained during a 10-min rest period during
which all catheters were flushed with heparinized saline to maintain patency.
At the end of the experimental procedures, the left forearm was
immersed in 44°C water for 20 min to define maximal CVC. Finally, cold stress was repeated when the subjects were vasodilated by heat
stress to reconfirm the effectiveness of the local adrenergic blockade.
Dehydration during the experiment was prevented by infusing normal
saline at a rate of 5 ml · kg
1 · h
1
during thermoneutral and 10 ml · kg
1 · h
1
during heat stress conditions. Saline infusion resulted in a slight
weight gain of 100-200 g during the course of the experiment.
Measurements
Thermal stress. Subjects were studied at rest in the supine position, with the lower body enclosed in a negative-pressure chamber that included a temperature-controlled water bath for immersion of the lower legs. The lower legs were immersed in the water bath that was set to 34°C. To control skin temperature over the rest of the body, the subjects wore a liquid-perfused garment that covered the entire body with the exception of the head, both forearms, and both lower legs and was perfused with water at 34°C. To examine the impact of cold stress on skin blood flow, the inlet for the water-perfused garment was rapidly switched to a 5°C water bath for 4 min and then returned to 34°C. To raise body core temperature, the water bath within the LBNP box was raised to 44°C.
Body core and skin temperature. Internal body temperature was measured with a thermocouple that was advanced through the nose into the esophagus to approximately the level of the left atrium. Depth of insertion was 25% of the subject's standing height. Mean skin temperature was recorded as a weighted average from thermocouples placed at seven sites over the body surface: forehead, upper arm, chest, forearm, abdomen, thigh, and calf (15).
Central hemodynamic variables.
Central venous pressure (CVP) was measured directly through a 4-Fr
catheter, inserted under local anesthesia into the left antecubital
vein and advanced to the superior vena cava. Catheter placement was
determined from body surface measurements and waveform analysis. CVP
was recorded with a Gold Statham P23 ID pressure transducer referenced
to the midaxillary line. Cardiac stroke volume (SV) was measured
noninvasively by impedance cardiography (model 304 B, Minnesota
Impedance Cardiograph) from four silver tape electrodes placed around
the neck and the torso, by using the equation of Kubicek et al. (12).
The impedance signals were recorded continuously and processed as the
ensemble average of all the cardiac cycles during each 30-s period. HR
was recorded on-line from an electrocardiogram, and cardiac output (CO)
was calculated by multiplying HR and SV. Arterial blood pressure was measured beat by beat with a noninvasive finger cuff (Ohmeda 2300 Finapress), and mean arterial pressure (MAP) was calculated from the
area under the curve. Systemic vascular conductance was calculated as
CO/(MAP
CVP) and expressed as liters per minute per 100 millimeters of Hg.
Forearm blood flow.
Forearm blood flow was measured in the right arm by venous occlusion
plethysmography (27). The hand and the elbow were comfortably rested on
pads elevating the forearm at an angle of ~30° from the
horizontal plane in an effort to allow free drainage of venous blood.
The hand was excluded from the circulation by cuff occlusion of the
wrist to 270-300 mmHg. A second pneumatic occlusion cuff, placed 1 cm above the elbow, was rapidly inflated (<1 s) to
48 mmHg three
times per minute to stop venous outflow for 8-10 s. The rate of
increase in forearm circumference was measured with a Whitney
mercury-in-Silastic strain gauge. Blood flow was calculated from the
linear part of the slope of the volume change and expressed as
milliliters per 100 milliliters of tissue per minute. FVC was calculated as forearm blood flow/(MAP
CVP) and expressed as milliliters per 100 milliliter tissue per minute per 100 millimeters Hg.
Skin blood flow.
Measurements of skin blood flow were performed in the left forearm by
using laser-Doppler velocimetry (floLAB, Moor Instruments). Briefly, a laser beam is transmitted to the skin through an optical fiber at a wavelength of 780 nm, and the reflected signal is returned through another pair of optical fibers to a photodiode. Light reflected
from moving red blood cells is shifted to a different wavelength that
is converted into a voltage output that is proportional to red blood
cell flux. A time constant of 0.1 s was used during recording of
laser-Doppler flux data. The laser probes have a sample surface area of
1 mm2 and a penetrating depth of 0.5-1.5 mm. Two
such probes were affixed with adhesive rings to the volar forearm in
sites without superficial veins that demonstrated high flux values and
pulsatile activity. As described in Experimental Protocol, one
skin site had been pretreated with bretylium tosylate.
Special care was taken to support the fiber-optic cables and to prevent
movements of the arm. CVC was calculated as the laser-Doppler signal
output in volts divided by MAP (V/100 mmHg). CVC was expressed in two
forms: 1) a percentage of peak CVC and 2) percentage of
control. Peak CVC was defined as the CVC during local heating of the
left forearm to 43°C for 30 min, and control was defined as the CVC
measured before the first application of LBNP in the thermoneutral condition.
Data Acquisition and Analysis
Data were recorded continuously with an eight-channel computerized data-acquisition system and averaged over 30-s periods (MacLab System, ADInstruments). The data used for analysis represent the last 30-s period of control before the initiation of LBNP and the last 30-s period of each level of LBNP. Forearm blood flow was calculated from the slope of the increase in arm circumference per unit time and represents the average of two to four measurements during each level of LBNP. All data are reported as means ± SE.The comparison of the hemodynamic responses at various levels of LBNP within and between the two thermal conditions was done by a repeated-measures ANOVA. Least squares linear regression was used to describe the functional relationship between two variables. The slopes of the regression lines were compared by paired t-test. Differences were considered significant at P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Cold Stress
Application of cold stress induced a significant reduction in CVC at the untreated skin site before (
28.6 ± 5.4%; P < 0.05) and after (
21.7 ± 3.6%; P < 0.05) the
experimental protocol. Iontophoresis of bretylium blocked the
cold-induced reduction in CVC before (+8.1 ± 4.9%;
P > 0.1) and after heating (
4.9 ± 2.6%; P > 0.1), demonstrating effective and persistent sympathetic vasoconstrictor blockade.
Body Temperature and Hemodynamic Responses to Heat Stress
Esophageal temperature increased from 36.8 ± 0.1 to 37.3 ± 0.1°C (P < 0.05) during heat stress and induced marked sweating in all subjects. Mean skin temperature also increased from 35.2 ± 0.1 to 35.7 ± 0.1°C (P < 0.05). CO increased by 1.3 ± 0.3 l/min because of a 20 ± 2.4 beats/min increase in HR, whereas cardiac SV was unchanged (Table 1). In the periphery, heat stress induced a more than threefold increase in FVC (from 5.7 ± 0.9 to 18.8 ± 1.3 ml · 100 ml tissue
1 · min
1 · 100 mmHg
1). CVC increased from 0.21 ± 0.07 (19.0 ± 3.9% maximum) to 1.02 ± 0.20 CU (108.8 ± 10.0% maximum) and from
0.36 ± 0.13 (10.1 ± 1.5% maximum) to 1.33 ± 0.17 CU (62.7 ± 5.1% maximum) during heat stress in the untreated and treated skin
sites, respectively. The increase in CVC during heat stress was smaller
in the bretylium-treated skin site than in the untreated skin site
(P < 0.05). Despite the increase in CO, the redistribution of
blood flow in the heated state reduced CVP (8.0 ± 0.6 to 6.1 ± 0.6 mmHg) and MAP (91 ± 3 to 80 ± 2 mmHg; P < 0.05).
|
Central Hemodynamic Response to LBNP
There was a graded reduction in CVP with each level of LBNP in both the normothermic and heat stress conditions (Table 1). Despite the lower resting CVP during heat stress, CVP at any given level of LBNP was similar in thermoneutral and heat stress conditions. Presyncopal symptoms occurred in only one subject during the last 30 s of
40
mmHg LBNP during heat stress. Data from this trial were not used in any analysis.
CO was consistently higher during passive heating at all levels of CVP
(Table 1). However, the slope of the linear relationship between CVP
and cardiac SV (Fig. 1) was similar in
thermoneutral and passive heating, indicating that the CVP-SV
relationship of the heart was not significantly influenced by the
increase in body core temperature.
|
Forearm Blood Flow Response to LBNP
During LBNP there was a linear relationship between the reduction in CVP and the decrease in FVC (Fig. 2). Heat stress increased the slope of this relationship from 0.46 ± 0.10 to 1.57 ± 0.30 ml · 100 ml
1
tissue · min
1 · 100 mmHg
1 per mmHg CVP (P < 0.05). FVC was
always greater during heat stress than during thermoneutral conditions
at all levels of CVP (P < 0.05). The linear relationship
between systemic vascular conductance and CVP was also shifted upward,
but the slope was not significantly different between thermoneutral and
passive heating, averaging 0.30 ± 0.05 and 0.48 ± 0.08 l · min
1 · 100 mmHg
1 per mmHg CVP, respectively (Fig. 2).
|
Skin Blood Flow Response to LBNP
We observed significant heterogeneity in the CVC response to LBNP (Fig. 3). At thermoneutral conditions, application of
60 mmHg LBNP produced a decrease in CVC (
10%)
in only 25% of the subjects. During
75 and
90 mmHg LBNP,
50 and 65% of the subjects showed a decrease in CVC, respectively.
During heat stress, application of
40 and
60 mmHg LBNP
produced a decrease in CVC in 43 and 57% of the subjects,
respectively. At bretylium-reated skin sites, LBNP was ineffective in
reducing CVC under thermoneutral or heat stress conditions. In
addition, LBNP elicited significant vasodilation at the
bretylium-treated skin site in three subjects. The group data are
presented in Fig. 4, illustrating the
relationship between CVC and CVP during LBNP under thermoneutral and
heat stress conditions.
|
|
Application of LBNP did not significantly influence mean skin
temperature in either thermoneutral or heat stress conditions. For
example, mean skin temperature averaged 35.2 ± 0.1°C before and
35.1 ± 0.2°C during
60 mmHg LBNP in thermoneutral
conditions and 35.7 ± 01°C before and 35.2 ± 0.2°C during
60 mmHg LBNP in heat stress (P > 0.05).
| |
DISCUSSION |
|---|
|
|
|---|
There are two major results of this study. First, the relationship between changes in FVC and CVP remains linear over a wide range of LBNP. This linear relationship is shifted to a higher FVC, and the slope is increased by elevations in body core temperature. These data illustrate the integration of thermoregulatory and cardiovascular reflexes, presumably at some site within the central nervous system. Second, laser-Doppler velocimetry consistently detected changes in CVC during thermal stimuli but failed to identify consistent vasoconstrictor responses to orthostatic stress.
We used selective body core heating to study the interaction between thermal and baroreflexes. This experimental approach was chosen to eliminate any possible influence of high skin temperature, either local or whole body, on vascular responses in the skin (17, 21). Oberle et al. (17) showed that the cutaneous vasomotor response in acral skin to painful intraneural stimulation or arousal was dependent on thermal status. Specifically, intraneural stimulation caused vasodilation when foot skin temperature was <0°C but produced vasoconstriction when the skin temperature was >33°C. These authors concluded that skin vasomotor responses to various stimuli are modulated by skin temperature and that mean skin temperature was more important than local skin temperature. In addition, warming a large portion of the skin surface to a high temperature will modify the overall hemodynamic response to venous pooling during LBNP and thereby alter the physiological signal responsible for eliciting a baroreflex response (18, 19). The data in Fig. 1 indicate that our heating protocol reduced resting CVP but did not alter the linear relationship between CVP and cardiac SV during LBNP. However, the greater changes in FVC during heat stress resulted in relatively smaller changes in CVP.
The upward shift and increase in slope of the FVC-CVP relationship
(Fig. 2) provide evidence that the baroreflex control of peripheral
blood flow (mostly skin) is modulated with regard to thermoregulatory
demands. It is generally assumed that the quantitative contribution of
muscle blood flow to the changes in FVC is not affected by thermal
stress (3, 4). In that respect, our results are similar to earlier
reports by Crossley et al. (2) and Johnson et al. (8), who found
greater reductions in FVC during bouts of LBNP of
50 or
70 mmHg, respectively, with increasing thermal stress. The
linearity of the CVP-FVC relationship over the entire range of
nonhypotensive and hypotensive LBNP suggests a single response
"element." One interpretation of these data is that the
cardiopulmonary baroreceptors represent the primary response element
with little additional contribution due to arterial baroreceptor
unloading. This interpretation is supported by Crandall et al. (1), who
found no change in the CVC in response to application of pulsatile
carotid pressure. The increase in slope of the FVC-CVP relationship
might suggest that heat stress increased the sensitivity of this
baroreflex. We chose an alternative analysis of these data and
evaluated the changes in FVC as a function of the level of LBNP. In
this analysis, it is assumed that with increasing levels of LBNP the
change in FVC would reach some asymptote representing the maximal
vasoconstrictor response. This analysis is shown graphically in Fig.
5 as a plot of the change in FVC as a
hyperbolic function of LBNP that saturates maximal vasoconstrictor
capacity (
FVCmax) at some high level of LBNP. Curve
fitting the data by using the following equation
|
FVCmax and the Km,
or the level of LBNP that produces 50% of
FVCmax.
A comparison of the mean responses indicates that
FVCmax increased from 5.2 ml · 100 ml
1 · min
1 · 100 mmHg
1 in thermoneutral conditions to 12.8 ml · 100 ml
1 · min
1 · 100 mmHg
1 during heat stress. One interpretation of this
analysis is that the capacity to respond to LBNP increased with heat
stress. This conclusion is consistent with the observations of Johnson
et al. (7, 8). The Km was unchanged by thermal
stress, averaging
27 and
24 mmHg LBNP, respectively.
These data suggest that the responsiveness of vascular control of FVC
during LBNP, presumably by baroreceptors, is unchanged by a mild
elevation of body core temperature.
|
Our laser-Doppler measurements demonstrate significant changes in CVC to thermal stimuli, i.e., a reduction by ~25% in the untreated skin site in response to cold stress and a 300-400% increase in response to heat stress. (Fig. 4) These findings are consistent with the reports by Kellogg et al. (11) and Crandall et al. (1). Interestingly, during heat stress, CVC was lower in the bretylium-treated than in the untreated skin site. A diminished vasodilator response in the skin to thermal stress has also been observed in studies using standard plethysmographic measurements of forearm blood flow after sympathectomy (5) and cutaneous nerve blockade (4) and in laser-Doppler studies after sinoaortic denervation (20). A similar trend was reported in two studies by Kellogg et al. (10, 11), in which thermal stress increased CVC by 419 ± 66 and 361 ± 57% in treated skin sites vs. 517 ± 90 and 497 ± 82% in untreated skin sites, respectively. Ryan et al. (20) speculated that the loss of baroreceptor input to the central nervous system associated with sinoaortic denervation may limit maximal thermoregulatory responses at some "central" site by a yet-undefined mechanism. However, the observation that both cutaneous nerve blockade and local bretylium iontophoresis reduce maximal cutaneous vasodilatation is in conflict with the view that the cutaneous vasodilator system is exclusively controlled by nonadrenergic mechanism.
In contrast to the thermal stimuli, nonhypotensive or hypotensive
levels of LBNP did not evoke significant reductions in CVC. There were
few subjects (n = 3) who showed consistent vasoconstrictor responses to LBNP. Even in these subjects, clear reductions in CVC were
only evident during application of LBNP greater than
40 mmHg.
More surprising was the one subject who showed substantial vasodilation
during LBNP. It is difficult to clearly interpret our laser-Doppler
findings in view of the plethysmographic data. One possibility is that
there is significant spatial heterogeneity in the skin blood flow
responses during LBNP. This conclusion is supported by a study from our
laboratory (14) that conducted topographical perfusion mapping of a
6.25-cm2 skin area by laser-Doppler scanning.
This study found uniform changes in CVC in ~90% of the skin during
cold stress and heat stress. In contrast, only 47% of the skin area
showed a reduction in CVC during
40 mmHg LBNP, 28% was
unaffected, and 26% showed an increase in CVC. One
possible interpretation is that the overall and hemodynamically
relevant blood flow response to LBNP is more accurately reflected by
the strain-gauge technique. Johnson et al. (9) have emphasized the
great region-to-region and study-to-study variability of the
laser-Doppler measurements and concluded that the region under
observation may be too small to have uniform responses or uniform
numbers of perfused capillaries from site to site.
Two earlier studies have also found no changes in CVC during
nonhypotensive LBNP (1, 25). However, Crandall et al. (1), Kellogg et
al. (11), and Tripathi and Nadel (24) have reported consistent
reductions in CVC in response to
30 or
40 mmHg LBNP, respectively. These data are in conflict with our laser-Doppler data
and with the work of Vissing et al. (26). The latter found no changes
in CVC or skin sympathetic nerve activity during 20 min of
50
mmHg LBNP. The reason for these inconsistencies is unclear. Possible
explanations may be the nonuniform nature of skin blood flow responses
to baroreceptor unloading and differences in the experimental protocol
with regard to the application of heat stress, i.e., whole body skin
heating vs. body core heating. For example, skin temperatures in the
studies by Kellogg et al. (10, 11) were 38-39°C, whereas our
protocol produced skin temperatures of 35.7°C. Taylor et al. (23)
have shown that 2°C differences in local skin temperature
significantly alter reflex cutaneous vasoconstriction in response to
mild exercise and concluded that the greatest changes may be observed
at local skin temperatures of
39°C. Hence, the >2.3°C
difference in mean skin temperature may impact the peripheral pooling
associated with LBNP and the reflex cardiovascular responses, including
those responses in the cutaneous vasculature. In the present study,
mean skin temperature was unchanged during LBNP, and little changes in
CVC were observed. It is possible that changes in mean skin temperature
contribute to the magnitude of the CVC response to LBNP, as suggested
by Vissing et al. (25). However, an alternative explanation is that
poor resolution of the baroreflex control of CVC is due to a
combination of individual differences in baroreflex control of CVC
(Fig. 5) and spatial heterogeneity associated with sampling skin blood
flow with laser-Doppler flow probes (15). Finally, our
plethysmographic measurements argue against the conclusion of Vissing
et al. (26) that the cutaneous circulation is not under baroreceptor control.
The skin blood flow response to LBNP at skin sites treated with
bretylium tosylate was also absent. One possible explanation would be
differences in the bretylium iontophoresis protocols. Kellogg et al.
(10) used a greater current density (400 µA/cm2) for only
10 min, equivalent to 4,000 µA · min · cm
2,
compared with 4,800 µA · min · cm
2
produced by our protocol. There were moderate differences
in the sizes of the iontophoresis chambers (0.64 vs. 3.1 cm2), and Kellogg et al. used propylene glycol as a
delivery solution, whereas we used pure water as solvent. However, both
methods produced effective adrenergic blockade on the basis of the
abolition of the reflex vasoconstriction during skin cooling. Because
pure water does not conduct current, the control sites in our study were not actually exposed to current without drug. Grossmann et al. (6)
have shown that iontophoresis may cause a current-related hyperemia
independent of the action of the administered agent. In the present
study, there was no difference in baseline CVC between the sites under
normothermic conditions, and the heat-induced CVC changes were greater
in the untreated site. Hence, we do not believe that our bretylium
iontophoresis protocol is an important confounding factor.
Another interesting question arising from our measurements is the putative mechanism by which CVC increased during severe LBNP. In theory, this could be a passive phenomenon if there is a reduction in arteriolar constriction in the vicinity. Alternatively, a vasodilator system may have been activated in association with presyncopal or emotional stress. Because CVC increases during LBNP were also observed in the heated state, when all vasoconstrictor tone is presumably released, active vasodilatation appears to be the most probable explanation. Such responses, when occurring more uniformly, may contribute importantly to orthostatic intolerance.
In summary, the present study suggests that there is an important central integration of thermoregulatory and baroreflexes directed to the cutaneous circulation. In addition, it is likely this interaction is mediated primarily by the cardiopulmonary baroreceptors. Our laser-Doppler data indicate significant regional heterogeneity of the skin blood flow responses to orthostatic stress. This latter observation, although intuitively puzzling, may be viewed as indirect evidence for the existence of a sympathetic active vasodilator system. A vasodilator component of skin sympathetic nerve activity (22) has been identified. Preliminary data from our laboratory (16) showed that this vasodilator component of skin sympathetic nerve activity was present at skin temperatures of 34°C. These observations, in combination with our present data, support the hypothesis that vasomotor response of the cutaneous vasculature to increased sympathetic nerve activity reflect a net balance between dilating and constricting effects. In addition, this net balance appears to be modulated by thermal status acting either centrally (Fig. 2) and/or locally (17).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. John Fahey and John Stofan for technical assistance and the volunteer subjects for time and cooperation.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grant HL-39818.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: G. W. Mack, John B. Pierce Laboratory, 290 Congress Ave., New Haven, CT 06519 (E-mail: mack{at}jbpierce.org).
Received 19 June 1998; accepted in final form 5 January 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Crandall, CG,
Johnson JM,
Kosiba WA,
and
Kellogg DL, Jr.
Baroreceptor control of the cutaneous active vasodilator system.
J Appl Physiol
81:
2192-2198,
1996
2.
Crossley, RJ,
Greenfeild ADM,
Plassaras GC,
and
Stephans D.
The interrelationship of thermoregulatory and baroreceptor reflexes in the control of blood vessels in the human forearm.
J Physiol (Lond)
183:
628-636,
1966
3.
Detry, JMR,
Brengelmann GL,
Rowell LB,
and
Wyss L.
Skin and muscle components of forearm blood flow in directly heated resting man.
J Appl Physiol
32:
506-511,
1972
4.
Edholm, OG,
Fox RH,
and
Macpherson RK.
The effect of body heating on the circulation in the skin and muscle.
J Physiol (Lond)
134:
612-619,
1956.
5.
Grant, RT,
and
Holling HE.
Further observations on the vascular responses of the human limb to body warming; evidence for sympathetic vasodilator nerves in the normal subject.
Clin Sci (Colch)
3:
273-285,
1938.
6.
Grossmann, M,
Jamieson MJ,
Kellogg DL, Jr,
Kosiba WA,
Pergola PE,
Crandall CG,
and
Shepherd AM.
The effect of iontophoresis on the cutaneous vasculature: evidence for current-induced hyperemia.
Microvasc Res
50:
444-452,
1995[ISI][Medline].
7.
Johnson, JM.
Nonthermoregulatory control of human skin blood flow.
J Appl Physiol
61:
1613-1622,
1986
8.
Johnson, JM,
Niederberger M,
Rowell LB,
Eisman MM,
and
Brengelmann GL.
Competition between cutaneous vasodilator and vasoconstrictor reflexes in man.
J Appl Physiol
35:
798-803,
1973
9.
Johnson, JM,
Taylor WF,
Shephard AP,
and
Park MK.
Laser-Doppler measurement of skin blood flow: comparison with plethysmography.
J Appl Physiol
56:
798-803,
1984
10.
Kellogg, DLJ,
Johnson JM,
and
Kosiba WA.
Selective abolition of adrenergic vasoconstrictor responses in skin by local iontophoresis by bretylium.
Am J Physiol Heart Circ Physiol
257:
H1599-H1606,
1989
11.
Kellogg, DLJ,
Johnson JM,
and
Kosiba WA.
Baroreflex control of cutaneous active vasodilator system in humans.
Circ Res
66:
1420-1426,
1990
12.
Kubicek, WG,
Patterson RP,
and
Witsoe DA.
Impedance cardiography as a non-invasive method of monitoring cardiac function and other parameters of the cardiovascular system.
Ann NY Acad Sci
170:
724-732,
1970.
13.
Lind, AR,
Leithead CS,
and
McNicol GW.
Cardiovascular changes during syncope induced by tilting men in the heat.
J Appl Physiol
25:
268-278,
1968
14.
Mack, GW.
Assessment of cutaneous blood flow by using topographical perfusion mapping techniques.
J Appl Physiol
85:
353-359,
1998
15.
Mack, GW,
Nishiyasu T,
and
Shi X.
Baroreceptor modulation of cutaneous vasodilator and sudomotor responses to thermal stress in humans.
J Physiol (Lond)
483:
537-547,
1995[ISI][Medline].
16.
Mack, GW,
and
Takeuchi S.
Active vasodilator component of skin sympathetic nerve activity in humans (Abstract).
FASEB J
13:
A386,
1999.
17.
Oberle, J,
Elam M,
Karlsson T,
and
Wallin BG.
Temperature dependent interaction between vasoconstrictor and vasodilator mechanisms in human skin.
Acta Physiol Scand
132:
459-469,
1988[ISI][Medline].
18.
Raven, PB,
Pape G,
Taylor WF,
Gaffney FA,
and
Blomqvist CG.
Hemodynamic changes during whole body surface cooling and lower body negative pressure.
Aviat Space Environ Med
52:
387-391,
1981[Medline].
19.
Raven, PB,
Saito M,
Gaffney FA,
Schutte J,
and
Blomqvist CG.
Interactions between surface cooling and LBNP-induced central hypovolemia.
Aviat Space Environ Med
51:
497-503,
1980[Medline].
20.
Ryan, KL,
Taylor WF,
and
Bishop VS.
Arterial baroreflex modulation of heat-induced vasodilation in the rabbit ear.
J Appl Physiol
83:
2091-2097,
1997
21.
Sakurada, S,
Shido O,
and
Nafasaka T.
Mechanism of vasoconstriction in the rat's tail when warmed locally.
J Appl Physiol
71:
1758-1763,
1991
22.
Sugenoya, J,
Iwase S,
Mano T,
Sugiyama Y,
Ogawa T,
Nishiyama T,
Nishimura N,
and
Kimura T.
Vasodilator component in sympathetic nerve activity destined for the skin of the dorsal foot of mildly heated humans.
J Physiol (Lond)
507:
603-610,
1998
23.
Taylor, WF,
Johnson JM,
O'Leary DS,
and
Park MK.
Modification of the cutaneous vascular response to exercise by local skin temperature.
J Appl Physiol
57:
1878-8184,
1984
24.
Tripathi, A,
and
Nadel ER.
Forearm skin and muscle vasoconstriction during lower body negative pressure.
J Appl Physiol
60:
1535-1541,
1986
25.
Vissing, SF,
Scherrer U,
and
Victor RG.
Increase of sympathetic discharge to skeletal muscle but not skin during mild lower body negative pressure in humans.
J Physiol (Lond)
481:
233-241,
1994[ISI][Medline].
26.
Vissing, SF,
Secher NH,
and
Victor RG.
Mechanisms of cutaneous vasoconstriction during upright posture.
Acta Physiol Scand
159:
131-138,
1997[ISI][Medline].
27.
Whitney, JR.
Measurement of volume changes in human limbs.
J Physiol (Lond)
121:
1-27,
1953.
This article has been cited by other articles:
![]() |
C. G. Crandall, T. E. Wilson, J. Marving, T. W. Vogelsang, A. Kjaer, B. Hesse, and N. H. Secher Effects of passive heating on central blood volume and ventricular dimensions in humans J. Physiol., January 1, 2008; 586(1): 293 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Wilson, C. Tollund, C. C. Yoshiga, E. A. Dawson, P. Nissen, N. H. Secher, and C. G. Crandall Effects of heat and cold stress on central vascular pressure relationships during orthostasis in humans J. Physiol., November 15, 2007; 585(1): 279 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tartas, P. Bouye, A. Koitka, V. Jaquinandi, L. Tan, J. L. Saumet, and P. Abraham Cathodal current-induced vasodilation to single application and the amplified response to repeated application in humans rely on aspirin-sensitive mechanisms J Appl Physiol, October 1, 2005; 99(4): 1538 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ito, T. Itoh, T. Hayano, K. Yamauchi, and A. Takamata Plasma hyperosmolality augments peripheral vascular response to baroreceptor unloading during heat stress Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R432 - R440. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Wilson, J. Cui, and C. G. Crandall Mean body temperature does not modulate eccrine sweat rate during upright tilt J Appl Physiol, April 1, 2005; 98(4): 1207 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tartas, P. Bouye, A. Koitka, S. Durand, Y. Gallois, J. L. Saumet, and P. Abraham Early vasodilator response to anodal current application in human is not impaired by cyclooxygenase-2 blockade Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1668 - H1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cui, T. E. Wilson, and C. G. Crandall Muscle sympathetic nerve activity during lower body negative pressure is accentuated in heat-stressed humans J Appl Physiol, June 1, 2004; 96(6): 2103 - 2108. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Scremin and W. L. Kenney Aging and the skin blood flow response to the unloading of baroreceptors during heat and cold stress J Appl Physiol, March 1, 2004; 96(3): 1019 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lee, D. N. Jackson, D. L. Cordero, T. Nishiyasu, J. K. Peters, and G. W. Mack Change in spontaneous baroreflex control of pulse interval during heat stress in humans J Appl Physiol, November 1, 2003; 95(5): 1789 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Durand, B. Fromy, M. Tartas, A. Jardel, J. L. Saumet, and P. Abraham Prolonged aspirin inhibition of anodal vasodilation is not due to the trafficking delay of neural mediators Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R155 - R161. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cui, T. E. Wilson, and C. G. Crandall Phenylephrine-induced elevations in arterial blood pressure are attenuated in heat-stressed humans Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1221 - R1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Mack, D. Cordero, and J. Peters Baroreceptor modulation of active cutaneous vasodilation during dynamic exercise in humans J Appl Physiol, April 1, 2001; 90(4): 1464 - 1473. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||